BioSpace News Archive

Pharm Country

Long-Term Efficacy and Safety Data of XCOPRI® (cenobamate tablets) CV Published in Neurology

SK Life Science, Inc., announced that the results of the long-term, open-label extension (OLE) of a randomized, double-blind, placebo-controlled study (C017) of XCOPRI® (cenobamate) were published online in the journal Neurology.

June 22, 2022
·
12 min read
Biotech Beach

NeuriTest™ Presented Publicly for the First Time at the International Society for Stem Cell Research Annual Meeting

Aspen Neuroscience, Inc. Director of Bioinformatics, Roy Williams , Ph.D., presented NeuriTest™ for the first time publicly last week at the 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting in San Francisco, Calif.

June 22, 2022
·
3 min read
Propanc Biopharma’s CSO Hails Dostarlimab’s Impressive Results Whilst Acknowledging More Work to Be Done in the Fight Against Cancer

Propanc Biopharma, Inc. today announced that the results from a small trial of just 18 rectal cancer patients in complete remission using an immunotherapy called dostarlimab are “impressive,” whilst acknowledging there’s more work to be done.

June 22, 2022
·
5 min read
BioMidwest

TriSalus Life Sciences Provides Update on Development of Immunotherapy Platform Approach for Liver and Pancreatic Tumors

TriSalus Life Sciences®, today highlighted a series of updates from clinical and pre-clinical studies that help support the company’s immunotherapy platform approach for treating liver and pancreatic tumors.

June 22, 2022
·
8 min read
Deals

FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF

FUJIFILM Irvine Scientific, Inc. announced it has exclusively licensed the intellectual property relating to artificial intelligence for image-based evaluation of human embryos to improve in-vitro fertilization success rates.

June 22, 2022
·
3 min read
U.S. Biopharmaceutical Third Party Logistics Market Size to Hit US$ 65.4 Bn by 2030

The U.S. Biopharmaceutical Third Party Logistics Market size was valued at US$ 38.9 billion in 2021 and is expected to hit US$ 65.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.

June 22, 2022
·
7 min read
Drug Development

BioAxone BioSciences Announces Patent Issued for Pharmaceutical Compositions of BA-210, a Rho Inhibitor for the Treatment of Spinal Cord Injury

BioAxone BioSciences, Inc., a clinical stage biotechnology company committed to discovering and developing drugs for neurological conditions, today announced that a new patent has been issued for BA-210, a Phase 3-ready pro-regenerative drug candidate for the treatment of spinal cord injury.

June 22, 2022
·
2 min read
Drug Development

Xoran Technologies Starts Work on Phase 2 of Mobile Lung CT NIH Grant

Today, Xoran Technologies® announces they have begun work on Phase 2 of their mobile lung grant with the goal to confirm the safety and utility of a future thoracic point-of-care CT system in support of an FDA 510k submission.

June 22, 2022
·
3 min read
Policy

FDA Infant Formula Update: June 22, 2022

The U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

June 22, 2022
·
4 min read
Drug Development

Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced new, compelling efficacy data supporting the late-stage, Phase 3 development of XEN1101.

June 22, 2022
·
6 min read